Literature DB >> 34854494

Frequency and Intensity of Premonitory Urges-to-Tic in Tourette Syndrome Is Associated With Supplementary Motor Area GABA+ Levels.

Jason L He1, Mark Mikkelsen2,3, David A Huddleston4, Deana Crocetti5, Kim M Cecil6, Harvey S Singer7,8, Richard A E Edden2,3, Donald L Gilbert4, Stewart H Mostofsky5,8,9, Nicolaas A J Puts1,10.   

Abstract

BACKGROUND: Individuals with Tourette syndrome (TS) often report that they express tics as a means of alleviating the experience of unpleasant sensations. These sensations are perceived as an urge to act and are referred to as premonitory urges. Premonitory urges have been the focus of recent efforts to develop interventions to reduce tic expression in those with TS.
OBJECTIVE: The aim of this study was to examine the contribution of brain γ-aminobutyric acid (GABA) and glutamate levels of the right primary sensorimotor cortex (SM1), supplementary motor area (SMA), and insular cortex (insula) to tic and urge severity in children with TS.
METHODS: Edited magnetic resonance spectroscopy was used to assess GABA+ (GABA + macromolecules) and Glx (glutamate + glutamine) of the right SM1, SMA, and insula in 68 children with TS (MAge  = 10.59, SDAge  = 1.33) and 41 typically developing control subjects (MAge  = 10.26, SDAge  = 2.21). We first compared GABA+ and Glx levels of these brain regions between groups. We then explored the association between regional GABA+ and Glx levels with urge and tic severity.
RESULTS: GABA+ and Glx of the right SM1, SMA, and insula were comparable between the children with TS and typically developing control subjects. In children with TS, lower levels of SMA GABA+ were associated with more severe and more frequent premonitory urges. Neither GABA+ nor Glx levels were associated with tic severity.
CONCLUSIONS: These results broadly support the role of GABAergic neurotransmission within the SMA in the experience of premonitory urges in children with TS.
© 2021 International Parkinson and Movement Disorder Society. © 2021 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  GABA; Tourette syndrome; glutamate; premonitory urges

Mesh:

Substances:

Year:  2021        PMID: 34854494      PMCID: PMC9014425          DOI: 10.1002/mds.28868

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   9.698


  47 in total

Review 1.  Dopaminergic Disturbances in Tourette Syndrome: An Integrative Account.

Authors:  Tiago V Maia; Vasco A Conceição
Journal:  Biol Psychiatry       Date:  2018-03-09       Impact factor: 13.382

2.  Transcranial magnetic stimulation at 1 Hertz improves clinical symptoms in children with Tourette syndrome for at least 6 months.

Authors:  Kai Le; Ling Liu; Manli Sun; Ling Hu; Nong Xiao
Journal:  J Clin Neurosci       Date:  2012-12-10       Impact factor: 1.961

3.  Role of the sensorimotor cortex in Tourette syndrome using multimodal imaging.

Authors:  Sule Tinaz; Beth A Belluscio; Patrick Malone; Jan Willem van der Veen; Mark Hallett; Silvina G Horovitz
Journal:  Hum Brain Mapp       Date:  2014-07-15       Impact factor: 5.038

4.  Motor cortex inhibition and modulation in children with ADHD.

Authors:  Donald L Gilbert; David A Huddleston; Steve W Wu; Ernest V Pedapati; Paul S Horn; Kathryn Hirabayashi; Deanna Crocetti; Eric M Wassermann; Stewart H Mostofsky
Journal:  Neurology       Date:  2019-07-17       Impact factor: 9.910

5.  Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome.

Authors:  Donald L Gilbert; Alok S Bansal; Gopalan Sethuraman; Floyd R Sallee; Jie Zhang; Tara Lipps; Eric M Wassermann
Journal:  Mov Disord       Date:  2004-04       Impact factor: 10.338

Review 6.  How do you feel--now? The anterior insula and human awareness.

Authors:  A D Bud Craig
Journal:  Nat Rev Neurosci       Date:  2009-01       Impact factor: 34.870

7.  Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial.

Authors:  Limor Dinur-Klein; Pinhas Dannon; Aviad Hadar; Oded Rosenberg; Yiftach Roth; Moshe Kotler; Abraham Zangen
Journal:  Biol Psychiatry       Date:  2014-06-05       Impact factor: 13.382

Review 8.  Sensory phenomena in obsessive-compulsive disorder and tic disorders: a review of the literature.

Authors:  Helena S Prado; Maria Conceição Rosário; Jennifer Lee; Ana G Hounie; Roseli G Shavitt; Eurípedes C Miguel
Journal:  CNS Spectr       Date:  2008-05       Impact factor: 3.790

9.  GABA and glutamate in children with Tourette syndrome: A 1H MR spectroscopy study at 7T.

Authors:  E Mark Mahone; Nicolaas A Puts; Richard A E Edden; Matthew Ryan; Harvey S Singer
Journal:  Psychiatry Res Neuroimaging       Date:  2018-01-03       Impact factor: 2.493

10.  Imaging the where and when of tic generation and resting state networks in adult Tourette patients.

Authors:  Irene Neuner; Cornelius J Werner; Jorge Arrubla; Tony Stöcker; Corinna Ehlen; Hans P Wegener; Frank Schneider; N Jon Shah
Journal:  Front Hum Neurosci       Date:  2014-05-28       Impact factor: 3.169

View more
  3 in total

1.  Classification of Alzheimer's Disease Based on Deep Learning of Brain Structural and Metabolic Data.

Authors:  Huiquan Wang; Tianzi Feng; Zhe Zhao; Xue Bai; Guang Han; Jinhai Wang; Zongrui Dai; Rong Wang; Weibiao Zhao; Fuxin Ren; Fei Gao
Journal:  Front Aging Neurosci       Date:  2022-07-12       Impact factor: 5.702

Review 2.  Tourette syndrome research highlights from 2021.

Authors:  Andreas Hartmann; Per Andrén; Cyril Atkinson-Clement; Virginie Czernecki; Cécile Delorme; Nanette Marinette Debes; Natalia Szejko; Keisuke Ueda; Kevin Black
Journal:  F1000Res       Date:  2022-06-29

3.  Urge-tic associations in children and adolescents with Tourette syndrome.

Authors:  Jennifer Langelage; Julius Verrel; Julia Friedrich; Alina Siekmann; Ronja Schappert; Annet Bluschke; Veit Roessner; Theresa Paulus; Tobias Bäumer; Christian Frings; Christian Beste; Alexander Münchau
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.